Adrian Hsing

Chief Development Officer
Head of Data Strategy and Innovation

 Mr. Hsing is a visionary leader in Clinical Data Sciences, known for driving innovation in data management, analytics, and emerging technologies. With a strategic mindset and a passion for transformation, he has led high-performing teams through complex organizational changes, including mergers and large-scale process optimizations, and has overseen over 10 successful NDA approvals. Before joining Pharmapace, Mr. Hsing held leadership roles at top biopharmaceutical companies such as Pfizer, Gilead Sciences, Elan Pharmaceuticals, Ultragenyx, and BioMarin. As Chief Development Officer and Head of Data Strategy and Innovation, he has transformed traditional data functions into advanced data science organizations by integrating AI/ML, automation, and data visualization—boosting data quality, operational efficiency, and decision-making. His deep expertise in Quality by Design (QbD), Risk-Based Monitoring (RBM), and Centralized Statistical Monitoring (CSM) has optimized clinical trial execution and compliance. A strong advocate for metric-driven methodologies, Mr. Hsing continues to elevate productivity and data integrity while positioning organizations at the forefront of clinical research innovation.